poisar

Stocks · News reference

Simulations Plus Clears HSR Waiting Period For Altaris Acquisition, Closing Expected In H2 2026

Benzinga Newsdesk

Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, announced the

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

SLP
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  3. Avi Kapoor

    Dow Gains 50 Points; Simulations Plus Earnings Top Views

    Dow Jones up 0.1% on Friday with NASDAQ and S&P 500 also rising. Communication services shares jumped 0.9% while health care fell 0.5%. Simulations Plus Inc beats earnings estimates, WD-40 Co and Jiuzi Holdings Inc see gains, eLong Power Holding Ltd and Virax Biolabs Group Ltd see losses. European shares mixed, Asian markets close mixed.

    ELPWEQPTJEMJZXNSLP